Supreme Court Verdict: Third-Party Drug Testers Not Liable for Negligence

In a landmark case that questioned the responsibilities of third-party drug testing entities when it comes to the termination of an employee, the Texas Supreme Court delivered a significant ruling. At the heart of the dispute was the issue of whether a third-party entity, hired by an employer to collect and test drug samples from employees, owed a common-law duty to perform these services with reasonable care. This article examines the details, legal arguments, and final outcome of this crucial case.

Background on the case and the role of third-party drug testing entities

The case involved an employee, referred to as the respondent, who worked as a pipefitter and had never tested positive for drug use during his employment. However, a particular drug test yielded a positive result for cocaine, which the respondent vehemently denied using. Consequently, the employee was required to complete a substance-abuse course by the Drug & Alcohol Testing Industry Association (DISA) before returning to work. Surprisingly, Turnaround, the respondent’s employer, refused to reassign him to any job site despite DISA’s approval.

Lawsuits and Claims against Third-Party Entities

Feeling wronged and unjustly terminated, the respondent filed a lawsuit against Turnaround. Eventually, he settled his claims with the employer and turned his attention towards Safety Council and Psychemedics, third-party entities responsible for collecting and processing his drug samples. According to the respondent, the alleged negligence of these entities led to his loss of employment. He sought legal redress for their alleged role in his termination.

Trial court and appellate court decisions

The trial court ruling came as a blow to the respondent when it determined that neither Safety Council nor Psychemedics owed him a legal duty. The court’s reasoning lay in the fact that these entities had no control over Turnaround’s decision to terminate the employee. However, on appeal, the Court of Appeals overturned the trial court’s decision. The appellate court found that a legal duty existed for third-party entities to use reasonable care in collecting and processing biological samples for drug testing.

Texas Supreme Court decision

The petitioners, Safety Council and Psychemedics, appealed the case to the Texas Supreme Court. In a definitive ruling, the Supreme Court sided with the petitioners, reversing the appellate court’s judgment. The court made it clear that third-party entities collecting or processing samples from employees did not owe a common-law duty of care. They highlighted that these entities had no control over the employer’s decision to terminate the employee, absolving them of any liability.

Arguments against imposing a new duty

The petitioners argued against imposing a new legal duty upon third-party drug testing entities, as it could lead to frivolous and burdensome claims. Additionally, they raised concerns about the potential transfer of responsibility, increased costs, and a decline in employment drug screens. They argued that imposing such a duty might prompt employers to take over the drug-testing programs themselves, potentially eroding the employment-at-will doctrine and exposing employers to further liability.

Implications and Consequences

Recognizing a new duty for third-party entities in collecting and processing samples from employees could have significant implications. Employers may choose to bring the drug testing program in-house to avoid potential liability, altering the current structure. This shift in responsibility might have consequences such as increased costs, delayed results, and potential conflicts of interest. Furthermore, it could undermine the employment-at-will doctrine, impacting employers’ flexibility in managing their workforce.

In a precedent-setting decision, the Texas Supreme Court ruled that third-party entities involved in collecting and processing employee drug samples do not owe a common-law duty to perform these services with reasonable care. The court’s reasoning emphasized the lack of control these entities had over the employer’s decision to terminate an employee. This ruling safeguards against potential frivolous claims, shields employers from unnecessary liability, and maintains the integrity of employment drug tests. However, it is essential to continue monitoring the evolving landscape around workplace drug testing and the role of third-party entities in ensuring a fair and responsible process.

Explore more

Ethlabs Launches to Drive Ethereum Institutional Adoption

The rapid convergence of legacy financial systems and decentralized infrastructure has reached a critical inflection point where the necessity for specialized, long-term technical stewardship is no longer optional for global stability. Ethlabs has entered the market as a nonprofit research and development powerhouse, specifically architected to facilitate the massive migration of institutional capital onto the Ethereum protocol. By creating a

Why Is Brand-Owned Identity the Future of Marketing?

The systemic erosion of third-party tracking mechanisms has fundamentally altered the digital landscape, forcing organizations to reconsider how they establish and maintain connections with their target audiences. As the reliance on external data providers becomes increasingly precarious due to shifting privacy regulations and the total phase-out of legacy tracking technologies, the concept of brand-owned identity has transitioned from a theoretical

How Can Financial Discipline Modernize Government IT?

The silent erosion of public trust often begins in the basement of a government building where servers that belong in a museum are still tasked with processing modern citizen demands. These “pensionable” systems have survived decades beyond their planned obsolescence, creating a precarious state where the risk of catastrophic failure or massive data breaches grows exponentially with each passing day

Is macOS 27 the End of the Road for Intel Macs?

The release of macOS 27, internally designated as Golden Gate, represents more than a simple seasonal update; it marks the definitive conclusion of the two-decade partnership between Apple and Intel. While previous years featured a gradual tapering of support, this iteration serves as the formal boundary where legacy hardware no longer meets the operational requirements of the modern Mac ecosystem.

Windows 11 Struggles to Close the Developer Sentiment Gap

The prevalence of Microsoft Windows 11 within modern enterprise environments masks a persistent and deepening dissatisfaction among the high-level developers who maintain our digital infrastructure. While industry data shows that nearly half of the global developer population utilizes Windows as their primary operating system, this statistical dominance is frequently a byproduct of corporate necessity rather than a reflection of genuine